ViiV AT EACS 2025
We are excited to announce that we will be presenting new data from our innovative HIV treatment and prevention portfolio at the European AIDS Clinical Society Conference (EACS) in Paris, France from 15-18 October 2025.
Our Innovative Portfolio at EACS 2025
Our presentations
We’ll be sharing data from 15 abstracts and 19 ViiV-supported and collaborative studies from our industry leading treatment and prevention portfolio, including 7 oral presentations and 27 poster presentations. Our data will focus on the role of our diverse portfolio in ending the HIV epidemic in Europe and globally.
You can find out more about our data and as well as the full conference programme here
100% DEDICATED
Our commitment to support people impacted by HIV, no matter who they are or where they live is unwavering and at EACS 2025, we’ll be using our platform to amplify the voices of the HIV community through various events throughout the conference.
This page will be updated with more information on our presence and activities soon.
RELATED PAGES:
U=U is a simple, concise and impactful abbreviation for Undetectable = Untransmittable. It signifies that individuals with HIV, undergoing treatment and maintaining an undetectable viral load, cannot transmit the virus to an HIV-negative partner.
We can end HIV through continuous innovation, global partnerships and talented people that help us reach the communities that are disproportionately impacted by HIV.
We believe in a comprehensive approach to HIV prevention that considers both medical and non-medical alternatives that are accessible to all. Ideally, a combination of strategies can be effective in reducing the likelihood of HIV transmission.
NP-GBL-HVX-WCNT-230025 | September 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
